Financhill
Back

Repligen Stock Predictions

Repligen Stock Forecast

  • Over the next 52 weeks, Repligen has on average historically risen by 18.3% based on the past 38 years of stock performance.
  • Repligen has risen higher in 22 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
  • Is Repligen Stock Undervalued?
    The current Repligen [RGEN] share price is $145.65. The Score for RGEN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Repligen Stock Go Up Next Year?

  • Over the next 52 weeks, Repligen has on average historically risen by 18.3% based on the past 38 years of stock performance.

Repligen Stock Rating

Sell
50
Repligen (RGEN) is a Sell

Is Repligen overpriced?

  • Repligen has risen higher in 22 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%

Repligen Stock Price History

Is RGEN stock going to rise?

  • The current trend is moderately bearish and RGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com

52-Week Data

52-Week High:
211.13
52-Week Low:
113.50

Prediction Charts

Market Cap:
8.2B
Price in USD:
145.65
Volume:
408.2K
Beta:
0.97

Technical Analysis

SMA50:
144.04
SMA100:
146.15
SMA200:
151.23
52-Wk Change:
-20.29%

Stock Predictions

  • Is Repligen stock public?
    Yes, Repligen is a publicly traded company.
  • What is the Repligen stock quote today?
    The Repligen stock price is 145.65 USD today.
  • How to buy Repligen stock online?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-4 148.50 149.09 150.78 145.97
Dec-5 147.87 142.26 148.17 142.15
Dec-6 143.78 149.20 150.56 143.24
Dec-9 150.35 154.72 156.94 149.97
Dec-10 154.71 151.94 156.75 150.56
Dec-11 153.54 155.25 157.25 152.34
Dec-12 153.13 155.99 157.91 153.13
Dec-13 156.54 156.41 158.07 151.50
Dec-16 155.37 160.92 161.24 155.37
Dec-17 159.94 158.14 160.65 157.24
Dec-18 158.23 147.34 160.05 146.45
Dec-19 147.26 146.54 149.32 143.91
Dec-20 145.70 144.47 150.56 143.96
Dec-23 144.05 145.65 146.49 141.20

Repligen Earnings

Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.

Repligen Forecast Revenue Growth

Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.19 per share.

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.